A New Mesothelioma Treatment Takes Aim at How Tumors Protect Themselves
An experimental drug called RSO-021 kept pleural mesothelioma from growing in two out of three evaluable patients after 12 weeks of treatment in an early clinical trial. The drug works by shutting down an enzyme that mesothelioma cells rely on to survive their own internal stress. It is not approved for general use and is …